Prestige Consumer Healthcare Inc. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD from Q2 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Prestige Consumer Healthcare Inc. quarterly/annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect history and growth rate from Q2 2018 to Q2 2024.
  • Prestige Consumer Healthcare Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending June 30, 2024 was -$12.2M, a 212% decline year-over-year.
  • Prestige Consumer Healthcare Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was -$12M, a 138% decline from 2022.
  • Prestige Consumer Healthcare Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2022 was $31.3M.
  • Prestige Consumer Healthcare Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2021 was -$5.12M, a 91.8% increase from 2020.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$12.2M -$8.3M -212% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q2 2023 -$3.91M -$12.6M -145% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q2 2022 $8.68M -$123M -93.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q2 2021 $131M +$168M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q2 2020 -$36.8M -$38.3M -2535% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q2 2019 $1.51M -$209K -12.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q2 2018 $1.72M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.